These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 17332345)
1. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. Morvan D; Demidem A Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345 [TBL] [Abstract][Full Text] [Related]
2. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Morvan D; Demidem A; Papon J; De Latour M; Madelmont JC Cancer Res; 2002 Mar; 62(6):1890-7. PubMed ID: 11912170 [TBL] [Abstract][Full Text] [Related]
3. Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming. Guénin S; Morvan D; Thivat E; Stepien G; Demidem A Nutr Cancer; 2009; 61(4):518-29. PubMed ID: 19838924 [TBL] [Abstract][Full Text] [Related]
4. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model. Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801 [TBL] [Abstract][Full Text] [Related]
5. Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics. Bayet-Robert M; Lim S; Barthomeuf C; Morvan D Biochem Pharmacol; 2010 Oct; 80(8):1170-9. PubMed ID: 20637732 [TBL] [Abstract][Full Text] [Related]
6. CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature. Merle P; Morvan D; Madelmont JC; Caillaud D; Demidem A Int J Oncol; 2006 Sep; 29(3):637-42. PubMed ID: 16865279 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced bystander effect in response to several chloroethylnitrosoureas: an origin independent of DNA damage? Merle P; Morvan D; Caillaud D; Demidem A Anticancer Res; 2008; 28(1A):21-7. PubMed ID: 18383820 [TBL] [Abstract][Full Text] [Related]
8. [The effect of antitumor preparations on the energy metabolism of melanoma B16 in mice. A 31P-NMR method in vivo]. Shkarin PIu; Sokolova IS; Gorbacheva LB; Sibel'dina LA Dokl Akad Nauk SSSR; 1989; 309(4):996-9. PubMed ID: 2635671 [No Abstract] [Full Text] [Related]
9. PP2A activity is controlled by methylation and regulates oncoprotein expression in melanoma cells: a mechanism which participates in growth inhibition induced by chloroethylnitrosourea treatment. Guénin S; Schwartz L; Morvan D; Steyaert JM; Poignet A; Madelmont JC; Demidem A Int J Oncol; 2008 Jan; 32(1):49-57. PubMed ID: 18097542 [TBL] [Abstract][Full Text] [Related]
10. Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells. Triba MN; Starzec A; Bouchemal N; Guenin E; Perret GY; Le Moyec L NMR Biomed; 2010 Nov; 23(9):1009-16. PubMed ID: 20963798 [TBL] [Abstract][Full Text] [Related]
11. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy. Mardor Y; Kaplan O; Sterin M; Ruiz-Cabello J; Ash E; Roth Y; Ringel I; Cohen JS Cancer Res; 2000 Sep; 60(18):5179-86. PubMed ID: 11016646 [TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642 [TBL] [Abstract][Full Text] [Related]
14. Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F-10 melanoma cells in C57BL/6 mice. Guruvayoorappan C; Kuttan G Integr Cancer Ther; 2007 Jun; 6(2):185-97. PubMed ID: 17548797 [TBL] [Abstract][Full Text] [Related]
15. Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy. Backshall A; Alferez D; Teichert F; Wilson ID; Wilkinson RW; Goodlad RA; Keun HC J Proteome Res; 2009 Mar; 8(3):1423-30. PubMed ID: 19159281 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment prediction of the chemotherapeutic response of human glioma cell cultures using nuclear magnetic resonance spectroscopy and artificial neural networks. El-Deredy W; Ashmore SM; Branston NM; Darling JL; Williams SR; Thomas DG Cancer Res; 1997 Oct; 57(19):4196-9. PubMed ID: 9331074 [TBL] [Abstract][Full Text] [Related]
17. An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: proof of principle. Spees WM; Gade TP; Yang G; Tong WP; Bornmann WG; Gorlick R; Koutcher JA Clin Cancer Res; 2005 Feb; 11(4):1454-61. PubMed ID: 15746046 [TBL] [Abstract][Full Text] [Related]
19. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines. Shyam K; Penketh PG; Loomis RH; Rose WC; Sartorelli AC J Med Chem; 1996 Feb; 39(3):796-801. PubMed ID: 8576923 [TBL] [Abstract][Full Text] [Related]
20. An assessment of the effects of sample ischaemia and spinning time on the metabolic profile of brain tumour biopsy specimens as determined by high-resolution magic angle spinning (1)H NMR. Opstad KS; Bell BA; Griffiths JR; Howe FA NMR Biomed; 2008 Nov; 21(10):1138-47. PubMed ID: 18666093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]